Cimzia Injection Approved for New Inflammatory Arthritis Indication

THURSDAY, March 28, 2019 -- Cimzia (certolizumab pegol) injection has been approved to treat adults with nonradiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation, the U.S. Food and Drug Administration announced.
The...

Source: Drugs.com - Pharma News - March 28, 2019 Category: Pharmaceuticals Source Type: news